miRNAs as biomarkers of adverse drug reactions to platinum-based agents in patients with non-small-cell lung cancer.

Authors :: Vasconcelos PE
Visacri MB
Pincinato EC
Torso NG
Seguin CS
Zambon L
Barbeiro AS
Junior MW
Moriel P
Source :: Biomarkers in medicine [Biomark Med] 2021 Sep; Vol. 15 (13), pp. 1067-1069. Date of Electronic Publication: 2021 Aug 17.
Publication Year :: 2021

Subjects :: Antineoplastic Combined Chemotherapy Protocols adverse effects
Biomarkers, Tumor blood
Carcinoma, Non-Small-Cell Lung genetics
Cisplatin administration & dosage
Cisplatin adverse effects
Drug-Related Side Effects and Adverse Reactions blood
Drug-Related Side Effects and Adverse Reactions diagnosis
Gene Expression Regulation, Neoplastic
Humans
Lung Neoplasms genetics
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor genetics
Carcinoma, Non-Small-Cell Lung drug therapy
Drug-Related Side Effects and Adverse Reactions genetics
Lung Neoplasms drug therapy
MicroRNAs genetics

Full Text Access

Tools